Austin, Daniel F. “Nomenclature of the Ipomoea nil complex (Convolvulaceae).” Taxon (1986).
2)Smith, Robin Ann, and Mark D. Rausher. “Experimental evidence that selection favors character displacement in the ivyleaf morning glory.” The American Naturalist 171.1 (2008).
3)Elmore, C. Dennis. “Mode of reproduction and inheritance of leaf shape in Ipomoea hederacea.” Weed Science 34.3 (1986).
4)Stinchcombe, John R., and Mark D. Rausher. “Diffuse selection on resistance to deer herbivory in the ivyleaf morning glory, Ipomoea hederacea.” The American Naturalist 158.4 (2001).
5)Schultes, Richard Evans, and A. Hofmann. “Plants of the Gods: Their Sacred, Healing, and Hallucinogenic Powers.” (1992).
6)Beyer, Jochen. “Herbal Psychoactive Substances.” (2013).
7)Ponce de León, Pedro. “Breve relación de los dioses y ritos de la gentilidad.” Garibay K., Ma. Teogonía e historia de los mexicanos. FCE. México (1996).
8)MacDougall, Thomas. “Ipomoea tricolor: a hallucinogenic plant of the Zapotecs.” Boletin del Centro de Investigación Antropológico de México 6 (1960).
9)Bah, Moustapha, and Rogelio Pereda-Miranda. “Isolation and structural characterization of new glyclipid ester type dimers from the resin of Ipomoea tricolor (Convolvulaceae).” Tetrahedron 53.27 (1997).
10)Pereda-Miranda, Rogelio, and Moustapha Bah. “Biodynamic constituents in the Mexican morning glories: purgative remedies transcending boundaries.” Current topics in medicinal chemistry 3.2 (2003).
11)Zia-Ul-Haq, Muhammad, Muhammad Riaz, and Vincenzo De Feo. “Ipomea hederacea Jacq.: a medicinal herb with promising health benefits.” Molecules 17.11 (2012).
12)Hofmann, Albert. “The active principles of the seeds of Rivea corymbosa and Ipomoea violacea.” Botanical Museum Leaflets, Harvard University 20.6 (1963).
13)Isbell, Harris, and C. W. Gorodetzky. “Effect of alkaloids of ololiuqui in man.” Psychopharmacologia 8.5 (1965).
14)Shulgin, A., and A. Shulgin. “26 LSD-25.” TiHKAL: A Continuation (1997).
15)Glässer, A. “Some pharmacological actions of d-lysergic acid methyl carbinolamide.” Nature 189.4761 (1961).
16)Nowak, Julia, et al. “Identification and determination of ergot alkaloids in Morning Glory cultivars.” Analytical and bioanalytical chemistry 408.12 (2016).
17)Webster, Peter, Daniel M. Perrine, and C. A. Ruck. “Mixing the kykeon.” Eleusis: Journal of Psychoactives Plants and Compounds 4 (2000).
18)YUI, TOHORU, and YUJI TAKEO. “NEUROPHARMACOLOGICAL STUDIES ON A NEW SERIES OF ERGOT ALKALOIDS ELYMOCLAVINE AS A POTENT ANALEPTIC ON RESERPINE-SEDATION.” The Japanese Journal of Pharmacology 7.2 (1958).
19)Beaulieu, Wesley T., et al. “Diversification of ergot alkaloids and heritable fungal symbionts in morning glories.” Communications Biology 4.1 (2021).
20)Wasson, R. Gordon, Albert Hofmann, and Carl AP Ruck. The road to Eleusis: Unveiling the secret of the mysteries. North Atlantic Books, 2008.
21)Brahmi, Fatiha, et al. “Chemical composition and biological activities of Mentha species.” Aromatic and medicinal plants-Back to nature 10 (2017).
22)Schultes, Richard Evans. A Contribution to Our Knowledge of Rivea Corymbosa: The Narcotic Ololinqui of the Aztecs. Botanical museum of Harvard university, 1941.
23)Austin, James E., and Heinz Fraenkel-Conrat. “Tryptophan analogues form adducts by cooperative reaction with aldehydes and alcohols or with aldehydes alone: possible role in ethanol toxicity.” Proceedings of the National Academy of Sciences 89.18 (1992).
24)Rosenkrans Jr, Charles F., and Nicholas S. Ezell. “Relationships among ergot alkaloids, cytochrome P450 activity, and beef steer growth.” Frontiers in chemistry 3 (2015).
25)Genest, K., and M. R. Sahasrabudhe. “Alkaloids and lipids of Ipomoea, Rivea and Convolvulus and their application to chemotaxonomy.” Economic Botany (1966).
26)COHEN, SIDNEY. “Suicide following morning glory seed ingestion.” American journal of psychiatry 120.10 (1964).
27)Ahmad, M., Zia-Ul-Haq M. Mehjabeen, and N. Jahan. “Determination of LD50 and ED50 by dose response relationship and assessment of toxicological and non toxicological behaviour of Ipomoea hederacea.” J. Pharm. Res 4.4 (2011).
28)Zia-Ul-Haq, Muhammad, et al. “Anticonvulsant and sex enhancing effects of Ipomoea hederacea seeds extract.” Farmacia 62 (2014).
29)YUI, TOHORU, and YUJI TAKEO. “NEUROPHARMACOLOGICAL STUDIES ON A NEW SERIES OF ERGOT ALKALOIDS ELYMOCLAVINE AS A POTENT ANALEPTIC ON RESERPINE-SEDATION.” The Japanese Journal of Pharmacology 7.2 (1958).
30)Abou-Chaar, C. I. “Alkaloids of an Ipomoea seed.” Lebanese Pharm J 9 (1967).
31)WATANABE, Hiroshi, et al. “Dopamine receptor stimulating effects of chanoclavine analogues, tricyclic ergot alkaloids, in the brain.” The Japanese Journal of Pharmacology 45.4 (1987).
32)Meira, Marilena, et al. “Review of the genus Ipomoea: traditional uses, chemistry and biological activities.” Revista Brasileira de Farmacognosia 22 (2012).
33)Abou-Chaar, Charles I., and George A. Digenis. “Alkaloids of an Ipomoea seed commonly known as Kaladana in Pakistan.” Nature 212.5062 (1966).
34)Dhar, T. Praveen, and N. Vijaya Kumar. “Phytochemical investigations in South Indian species of Ipomoea Linn.” The Journal of Indian Botanical Society 92.1and2 (2013).
35)Ahmad, M., Zia-Ul-Haq M. Mehjabeen, and N. Jahan. “Determination of LD50 and ED50 by dose response relationship and assessment of toxicological and non toxicological behaviour of Ipomoea hederacea.” J. Pharm. Res 4.4 (2011).
36)Suhail, Shahid, et al. “Habb-e-Suranjaan: A classical analgesic Unani formulation.” Int. J. Adv. Pharm. Med. Bioallied. Sci 2017 (2017).
37)Ahmad, M., Zia-Ul-Haq M. Mehjabeen, and N. Jahan. “Determination of LD50 and ED50 by dose response relationship and assessment of toxicological and non toxicological behaviour of Ipomoea hederacea.” J. Pharm. Res 4.4 (2011).
38)Reichmann, Heinz, et al. “Ergoline and non-ergoline derivatives in the treatment of Parkinson’s disease.” Journal of neurology 253.4 (2006).
39)Chaudhry, Mueen Ahmad, et al. “Ipomoea hederacea Jacq.: A plant with promising antihypertensive and cardio-protective effects.” Journal of Ethnopharmacology 268 (2021).
40)PParekh, K. K., et al. “Antioxidant and cytotoxic activities of few selected Ipomoea species.” Pharmacologia 3.9 (2012).
41)Zia-Ul-Haq, M., et al. “Biological screening of selected flora of Pakistan.” Biological research 45.4 (2012). species.” Pharm 3 (2012).
42)Agrawal, Krishn Kumar, et al. “Determination of extractive value, phytochemical constituents and In-vitro anti-urolithiatic activity of Embelia ribes burm. F. and Ipomea hederacea Jacq.” Research Journal of Pharmacy and Technology 14.7 (2021).
43)Chandur, Uma, et al. “EVALUATION OF THE ANTI-BACTERIAL AND ANTI-FUNGAL ACTIVITY OF IPOMOEA HEDERACEA.”
44)Zia-Ul-Haq, M., et al. “Antimicrobial screening of selected flora of Pakistan.” Archives of Biological Sciences 63.3 (2011).
45)Wilkinson, R. E., W. S. Hardcastle, and C. S. McCormick. “Ergot alkaloid contents of Ipomoea lacunosa, I. hederaceae, I. trichocarpa, and I. purpurea seed.” Canadian journal of plant science 66.2 (1986).
46)Dhar, T. Praveen, and N. Vijaya Kumar. “Phytochemical investigations in South Indian species of Ipomoea Linn.” The Journal of Indian Botanical Society 92.1and2 (2013).